A Phase 4 interventional study of Nicotine replacement therapy patches and Oral nicotine pouches in Smoking ( Cigarette), sponsored by Medical University of South Carolina. Enrolling by invitation at 1 site in United States. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by Medical University of South Carolina · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Cigarette Smoking by Medical University of South Carolina — 6 open to participants now, 6 under way, none of them phase 3. Cigarette Smoking · Medical University of South Carolina.
Among the 15 studies in Cigarette Smoking by Medical University of South Carolina, this one is the 15th largest by planned enrollment, is the only one that started in 2026, is the only one in phase 4, and was the 15th registered.
477 studies on the registry are indexed under Cigarette Smoking; 87 are open to participants now.
Browse Cigarette Smoking studies →6 of the 15 studies in Cigarette Smoking by Medical University of South Carolina are open now, in 1 country. Recruiting first, the newest first:
Medical University of South Carolina · Sites in United States
Ages 21+ · Healthy volunteers
Medical University of South Carolina · Sites in United States
Ages 21+ · Healthy volunteers
Medical University of South Carolina · Sites in United States
Ages 21+ · Healthy volunteers
Medical University of South Carolina · Sites in United States
Ages 21+
Medical University of South Carolina · Sites in United States
Ages 22–70 · Healthy volunteers
By country, each count listing its studies:
Of the 62 Cigarette Smoking studies recruiting now, 38 (61%) set no upper age limit and 18 (29%) stop at 75 or younger; 1 takes children under 18; 33 take healthy volunteers.
This study: 21 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 3 · Phase 4 1
First in 2009; this study’s year is marked. 1 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 10 is below the median of 96 across 407 interventional studies indexed under Cigarette Smoking.
Median enrollment 99 across the 15 interventional studies. Of the 9 that completed or were terminated, 8 (89%) have results posted.
This tab as a report to print or save as PDF → With an account.
Medical University of South Carolina is the lead sponsor of 875 studies on the registry; 165 are open to participants now.
Of its 132 completed or terminated interventional studies of FDA-regulated products, 104 (79%) have results posted.
5 of the studies in Cigarette Smoking by Medical University of South Carolina that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06678789Medical University of South CarolinaEvaluation of Low and High Nicotine Tobacco Free Nicotine Pouches | 2027-01-01 |
| NCT05019495Medical University of South CarolinaOptimizing Tobacco Treatment Delivery for People Living With HIV | 2027-02-01 |
| NCT07625956Medical University of South CarolinaPiloting Novel Interventional Strategies to Improve Nicotine Pouches as a Substitute for Smoking | 2027-02-28 |
| NCT04903028Medical University of South CarolinaRTMS Targets Neural Circuits for Smoking Cessation | 2027-02-28 |
| NCT06373679Medical University of South CarolinaSwitch or Quit R01 | 2027-05-01 |
Add all 5 to your calendar (.ics) → With an account.
Among the 15 studies in Cigarette Smoking by Medical University of South Carolina, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Some people who smoke cigarettes try to switch to oral nicotine pouches but are not able to fully stop smoking. This study tests two new strategies for people who previously tried to switch using nicotine pouches. Participants who were unable to fully switch will either be asked to increase the nicotine strength of their pouches or to use a nicotine patch along with pouches. The goal of the study is to see whether these strategies are feasible, acceptable, and helpful, and to inform the design of larger future studies.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Increase nicotine content of pouches
Drug: Oral nicotine pouches
Add nicotine replacement therapy
Drug: Nicotine replacement therapy patches
Participants will continue with their treatment from the parent trial.
Nicotine replacement therapy patches will be dosed based on current cigarette smoking at the end of the parent trial.
Zyn oral nicotine pouches will be provided in the flavor preference of the participant and dosed based on their randomization in the parent trial and randomization in the extension study.
Feasibility
Feasibility endpoints include 1) the proportion of eligible subjects who subsequently enroll; 2) the proportion of enrolled subjects who complete the Day 28 and Day 56 assessments; and 3) the proportion of enrolled subjects who complete ≥80% of their daily surveys during the switching period.
Time frame: Days 1-56
Acceptability
Acceptability endpoints will be measured by the Acceptability of Intervention Measure (AIM). This measure includes 4 items rated on scale of 1 to 5. Scores are created by averaging responses, with values ranging from 1 to 5. Higher values indicate higher acceptability.
Time frame: Day 28
Plan to share: Yes — Data from this study may be shared, by reasonable request, with other investigators not affiliated with the tobacco industry.
No publications or documents are linked to this record.
Started Jun 2026 (actual). Primary completion is estimated for Feb 2027, 8 months after the start.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 16, 2026: primary completion Oct 2026 → Feb 2027 and completion Oct 2026 → Mar 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medical University of South Carolina →